Skip to main content

Table 4 Unmet information needs

From: A survey of cancer patients’ unmet information and coordination needs in handovers – a cross-sectional study

  Overall unmet information needs Unmet information needs at hospital discharge# Unmet information needs in handovers between internal hospital departments## Unmet information needs in handovers between hospitals###
  N (%) OR (95% CI) ORadja(95% CI) N (%) OR (95% CI) ORadja(95% CI) N (%) OR (95% CI) ORadja(95% CI) N (%) OR (95% CI) ORadja(95% CI)
Demographic characteristics
Gender
 Women 19 (19%) 1.00 1.00 14 (16%) 1.00 1.00 8 (12%) 1.00 1.00 12 (13%) 1.00 1.00
 Men 4 (12%) 0.57 (0.18; 1.83) 1.10 (0.31; 3.93) 4 (25%) 1.71 (0.48; 6.09) 2.24 (0.58; 8.64) 3 (21%) 2.05 (0.47; 8.94) 3.31 (0.66; 16.59) 4 (12%) 0.97 (0.29; 3.23) 2.77 (0.63; 11.20)
Age
 <60 years of age 13 (33%) 1.00 1.00 9 (26%) 1.00 1.00 6 (23%) 1.00 1.00 9 (24%) 1.00 1.00
 ≥60 years of age 10 (11%) 0.24*(0.10; 0.62) 0.26*(0.10; 0.70) 9 (13%) 0.42 (0.15; 1.19) 0.36 (0.12; 1.07) 5 (9%) 0.33 (0.09; 1.19) 0.26 (0.07; 1.05) 7 (8%) 0.27*(0.09; 0.79) 0.23*(0.07; 0.80)
Marital status
 No partner 8 (29%) 1.00 1.00 7 (29%) 1.00 1.00 2 (13%) 1.00 1.00 5 (19%) 1.00 1.00
 Partner 15 (15%) 0.43 (0.16; 1.16) 0.39 (0.13; 1.16) 11 (14%) 0.40 (0.13; 1.18) 0.39 (0.12; 1.24) 9 (13%) 1.01 (0.19; 5.23) 0.63 (0.10; 3.78) 11 (11%) 0.54 (0.17; 1.71) 0.47 (0.12; 1.88)
Education
 Not higher education 7 (10%) 1.00 1.00 6 (12%) 1.00 1.00 4 (9%) 1.00 1.00 2 (3%) 1.00 1.00
 Higher education 16 (29%) 3.60*(1.36; 9.52) 3.41*(1.23; 9.44) 12 (24%) 2.43 (0.83; 7.11) 2.53 (0.84; 7.59) 7 (19%) 2.28 (0.61; 8.49) 2.72 (0.67; 11.09) 14 (26%) 11.90*(2.57; 55.08) 13.88*(2.78; 67.23)
Clinical characteristics
Comorbidity
 No comorbidity 8 (20%) 1.00 1.00 6 (19%) 1.00 1.00 4 (14%) 1. 00 1.00 4 (10%) 1.00 1.00
 Yes comorbidity 15 (16%) 0.79 (0.30; 2.07) 1.35 (0.45; 4.05) 12 (18%) 0.93 (0.31; 2.75) 1.33 (0.40; 4.38) 7 (14%) 1.02 (0.27; 3.82) 2.17 (0.43; 10.91) 12 (14%) 1.46 (0.44; 4.85) 3.51 (0.82; 15.09)
Treatment
Surgery
 No surgery 3 (9%) 1.00 1.00 3 (21%) 1.00 1.00 3 (20%) 0.55 1.00 3 (9%) 1.00 1.00
 Surgery 20 (21%) 2.72 (0.75; 9.81) 2.98 (0.35; 25.77) 15 (17%) 0.76 (0.19; 3.07) 1.21 (0.12; 12.24) 8 (12%) 0.54 (0.13; 2.35) 0.63 (0.02; 15.89) 13 (14%) 1.66 (0.44; 6.22) 3.30 (0.23; 46.73)
Radiation
 No radiation 10 (20%) 1.00 1.00 10 (30%) 1.00 1.00 2 (15%) 1.00 1.00 7 (14%) 1.00 1.00
 Radiation 13 (16%) 0.81 (0.32; 2.01) 0.73 (0.26; 2.01) 8 (12%) 0.31*(0.11; 0.87) 0.33 (0.11; 1.01) 9 (13%) 0.83 (0.16; 4.35) 0.75 (0.13; 4.42) 9 (12%) 0.83 (0.29; 2.40) 0.93 (0.28; 3.11)
Chemotherapy
 No chemotherapy 8 (13%) 1.00 1.00 7 (17%) 1.00 1.00 5 (14%) 1.00 1.00 8 (13%) 1.00 1.00
 Chemotherapy 15 (22%) 1.91 (0.75; 4.88) 1.10 (0.30; 4.06) 11 (18%) 1.09 (0.38; 3.09) 1.21 (0.31; 4.82) 6 (13%) 0.98 (0.27; 3.53) 1.15 (0.18; 7.53) 8 (12%) 0.93 (0.33; 2.65) 0.43 (0.08; 2.26)
Hormones
 No hormones 8 (27%) 1.00 1.00 6 (26%) 1.00 1.00 3 (19%) 1.00 1.00 3 (10%) 1.00 1.00
 Hormones 15 (15%) 0.49 (0.18; 1.29) 0.45 (0.15; 1.33) 12 (15%) 0.52 (0.17; 1.57) 0.50 (0.15; 1.67) 8 (12%) 0.60 (0.14; 2.57) 0.50 (0.10; 2.52) 13 (13%) 1.31 (0.35; 4.95) 1.38 (0.30; 6.40)
Years since diagnosis
 <3 years 11 (18%) 1.00 1.00 7 (16%) 1.00 1.00 6 (15%) 1.00 1.00 9 (16%) 1.00 1.00
 ≥3 years 12 (17%) 0.92 (0.37; 2.27) 0.99(0.35; 2.78) 11 (19%) 1.26 (0.45;3.58) 1.65(0.50; 5.47) 5 (12%) 0.81 (0.23; 2.90) 1.00 (0.24; 4.15) 7 (10%) 0.60 (0.21; 1.74) 0.81(0.23; 2.87)
  1. aAdjusted for age, gender and education, * P < 0.050, #Consists of 102 patient responses, ##Consists of 82 patient responses, ###Consists 129 patient responses.